Related Experiment Video
Updated: Jul 14, 2026

11:16
Engineering Platform and Experimental Protocol for Design and Evaluation of a Neurally-controlled Powered Transfemoral Prosthesis
Published on: July 22, 2014
Early clinical experience with the mobi-C disc prosthesis
Sang Hyun Kim1, Hyun Chul Shin, Dong Ah Shin
1Department of Neurosurgery, Yonsei University College of Medicine, 250 Seongsanno, Seodaemun-gu, Seoul 120-752, Korea.
Yonsei Medical Journal
|June 28, 2007
Summary
Cervical disc replacement with the Mobi-C prosthesis shows favorable short-term results for degenerative cervical disc disease, significantly reducing pain and preserving motion. Further long-term studies are needed to confirm efficacy and adjacent segment disease prevention.
Area of Science:
- Orthopedics
- Neurosurgery
- Spinal Surgery
Background:
- Degenerative cervical disc disease is a common condition requiring effective treatment.
- Cervical disc replacement (CDR) is an alternative to fusion for managing cervical disc disease.
- The Mobi-C prosthesis is a specific implant used for CDR.
Purpose of the Study:
- To evaluate the radiological outcomes and clinical efficacy of Mobi-C cervical disc replacement.
- To assess the safety and effectiveness of Mobi-C in treating degenerative cervical disc disease.
Main Methods:
- A prospective study of 23 patients undergoing Mobi-C CDR for degenerative cervical disc disease.
- Analysis of radiological results and clinical outcomes including pain scores (VAS) and functional ratings (Odom's criteria, Prolo scale).
- Assessment of range of motion (ROM) at the operated segment and adjacent levels.
Main Results:
- Significant reduction in axial pain (VAS 6.47 to 1.4) and radiculopathy pain (VAS 6.7 to 0) (p < 0.001).
- 100% of patients achieved excellent, good, or fair outcomes by Odom's criteria at 6 months post-op.
- Range of motion was well preserved at the operated segment (C2-7) and adjacent levels.
Conclusions:
- Mobi-C CDR demonstrates favorable short-term clinical and radiological outcomes for degenerative cervical disc disease.
- This study represents early documentation of Mobi-C CDR in this patient population.
- Long-term follow-up is necessary to establish sustained efficacy and evaluate adjacent segment disease prevention.

